Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-ELK3V90G6C? Is UNII-ELK3V90G6C safe for nursing mother and child? Does UNII-ELK3V90G6C extracts into breast milk? Does UNII-ELK3V90G6C has any long term or short term side effects on infants? Can UNII-ELK3V90G6C influence milk supply or can UNII-ELK3V90G6C decrease milk supply in lactating mothers?

UNII-ELK3V90G6C lactation summary

UNII-ELK3V90G6C usage has low risk in breastfeeding
  • DrLact safety Score for UNII-ELK3V90G6C is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of UNII-ELK3V90G6C may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that UNII-ELK3V90G6C may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of UNII-ELK3V90G6C low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using UNII-ELK3V90G6C We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About UNII-ELK3V90G6C usage in lactation

Fusion protein used for treatment of Psoriasis. Because a high molecular weight excretion into breast milk must be minimal or nil. Protein structure renders gastro-intestinal absorption unlikely.

Alternate Drugs for Immunosuppressive Agents. ATC L04

Natalizumab(Low Risk)
Sirolimus(Unsafe)
Fingolimod(Unsafe)
Abatacept(Low Risk)
Anakinra(Low Risk)
Belimumab(Low Risk)
Basiliximab(Low Risk)
Tocilizumab(Low Risk)
Ustekinumab(Low Risk)
Leflunomide(Dangerous)
Secukinumab(Low Risk)
Daclizumab(Low Risk)
Alefacept(Low Risk)
Atlizumab(Low Risk)
CTLA4-Ig(Low Risk)
BMS-188667(Low Risk)
D2E7(Safe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.